ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study

Running, not enrolling

Conditions studied: Neonatal Opioid Withdrawal Syndrome

In brief

The objective of this longitudinal cohort study is to quantify the effects of antenatal opioid exposure on the trajectory of brain development over the first 2 years of life, examine associations with developmental and neurobehavioral outcomes, and explore how specific factors (differing antenatal and postnatal exposures, severity of neonatal opioid withdrawal, maternal stress/depression/parenting) modify these effects

Key facts

Study ID
NCT04149509
Run by
Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program
People needed
300
Starts
2020-08-19
Expected to finish
2026-12-01
Last updated by the study team
2025-01-29

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.